Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407376
Max Phase: Preclinical
Molecular Formula: C34H39N3O6
Molecular Weight: 585.70
Molecule Type: Small molecule
Associated Items:
ID: ALA2407376
Max Phase: Preclinical
Molecular Formula: C34H39N3O6
Molecular Weight: 585.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]([C@@H](Oc1ccc(C=O)cc1)c1ccccc1)N1CN(C)[C@@H](CC(C)C)C1=O
Standard InChI: InChI=1S/C34H39N3O6/c1-23(2)19-29-33(40)37(22-36(29)3)30(32(39)35-28(34(41)42-4)20-24-11-7-5-8-12-24)31(26-13-9-6-10-14-26)43-27-17-15-25(21-38)16-18-27/h5-18,21,23,28-31H,19-20,22H2,1-4H3,(H,35,39)/t28-,29-,30-,31-/m0/s1
Standard InChI Key: XJLITHYHBWDOJM-ORYMTKCHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 585.70 | Molecular Weight (Monoisotopic): 585.2839 | AlogP: 4.03 | #Rotatable Bonds: 13 |
Polar Surface Area: 105.25 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.10 | CX Basic pKa: 3.95 | CX LogP: 5.17 | CX LogD: 5.17 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.24 | Np Likeness Score: 0.58 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):